GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (STU:NR1A) » Definitions » Days Sales Outstanding

National Research (STU:NR1A) Days Sales Outstanding : 30.32 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is National Research Days Sales Outstanding?

National Research's average Accounts Receivable for the three months ended in Mar. 2024 was €10.8 Mil. National Research's Revenue for the three months ended in Mar. 2024 was €32.5 Mil. Hence, National Research's Days Sales Outstanding for the three months ended in Mar. 2024 was 30.32.

The historical rank and industry rank for National Research's Days Sales Outstanding or its related term are showing as below:

STU:NR1A' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.73   Med: 34.3   Max: 40.76
Current: 31.73

During the past 13 years, National Research's highest Days Sales Outstanding was 40.76. The lowest was 31.73. And the median was 34.30.

STU:NR1A's Days Sales Outstanding is ranked better than
67.55% of 641 companies
in the Healthcare Providers & Services industry
Industry Median: 46.87 vs STU:NR1A: 31.73

National Research's Days Sales Outstanding declined from Mar. 2023 (36.07) to Mar. 2024 (30.32).


National Research Days Sales Outstanding Historical Data

The historical data trend for National Research's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Days Sales Outstanding Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.20 36.52 32.88 32.91 33.49

National Research Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.07 33.16 31.48 32.61 30.32

Competitive Comparison of National Research's Days Sales Outstanding

For the Health Information Services subindustry, National Research's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where National Research's Days Sales Outstanding falls into.



National Research Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

National Research's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (13.651 + 11.351) / 2 ) / 136.248*365
=12.501 / 136.248*365
=33.49

National Research's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (11.351 + 10.237) / 2 ) / 32.488*365 / 4
=10.794 / 32.488*365 / 4
=30.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Research  (STU:NR1A) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


National Research Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of National Research's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (STU:NR1A) Business Description

Traded in Other Exchanges
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.

National Research (STU:NR1A) Headlines

No Headlines